Capital Markets Day Presentation. November 2017
|
|
- Coral Hoover
- 6 years ago
- Views:
Transcription
1 Capital Markets Day Presentation November 2017
2 Disclaimer This information contained in the Capital Markets Day Presentation has been prepared by NMC Health and was compiled from sources believed to be reliable for informational purposes only. Prospective and existing investors should make their own evaluation of the company as the information provided here does not purport to be all inclusive or to contain all of the information a prospective or existing investor may desire. In all cases, interested parties should conduct their own investigation and analysis of the Company and the date set forth in this information. NMC Health makes no representation or warranty as to the accuracy or completeness of this information and shall not have any liability for any representations (expressed or implied) regarding information contained in, or for any omissions from, this information or any other written or oral communications transmitted to the recipient in the course of its evaluation of the Company. This presentation may contain forward looking statements including statements regarding our intent, belief or current expectations with respect to NMC s businesses and operations. Such forward-looking information and statements reflect current views with respect to future events and are subject to risks, uncertainties and assumptions. The Company cannot give assurance to the correctness of such information and statements. Many actual events and circumstances are beyond the control of the Company. 2
3 Agenda 1 Welcome note from the CEO 2 NMC Healthcare Managing rapid growth 3 NMC Fertility Building a global business 4 NMC Distribution Capitalizing on synergies with Healthcare 5 Q&A 3
4 Changing lives and impacting society positively 4
5 Agenda 1 Welcome note from the CEO 2 NMC Healthcare Managing rapid growth 3 NMC Fertility Building a global business 4 NMC Distribution Capitalizing on synergies with Healthcare 5 Q&A 5
6 Institutionalizing the business Focus on maintaining operational excellence Drive organisation culture Oversee quality, safety and patient satisfaction Oversite of financial expectations through oversight of operations Oversight of healthcare operations Manage relationships with regulatory agencies Mitigate risks and potential barriers to success Physician relations 6
7 Philosophy and methodology Enhancing NMC s current leadership framework by introducing concepts acquired from extensive experience in the US and UAE Maintain NMC s strong Abu Dhabi legacy while introducing a more western approach to organizational structure and decision making Create a corporate leadership hierarchy that focuses on the five pillars needed for our long term success: Cost, quality, service, growth, and people New management structure introduced to decentralize decision making Operational clusters created within the UAE and broader Middle East to empower front line leadership to control their business The new structure eliminates hurdles to quick decision making at the ground level and streamlines operations Previously higher level decisions regarding HR, operations, and business development were elevated to the corporate leadership Committed to evaluation of existing operational leadership across all portfolios and making changes if necessary 7
8 New corporate structure CEO Prasanth Manghat COO-Healthcare Michael Davis COO-Distribution Nirman Shetty Head of IVF Prakash Janardan Director Corporate Services Ravi Rai CFO Prashant Shenoy CMO Dr. C R Shetty CIO Hani Buttikhi Dy. COO Distribution Head of Clinica Eugin Head of Fakih IVF Business development Regional Head Abu Dhabi and Al Ain Regional Head Dubai and Northern Emirates Head Outside of UAE Head of Operations Abu Dhabi, Al Ain and Dubai Head of Operations Sharjah, Oman, Kuwait and Qatar Head of Operations Saudi Arabia Head of Human Resources and Personnel Head of Marketing and Sales Head of Quality Head of Nursing Investor Relations Corporate Development Mergers and Acquisitions Dy. CFO accounts and audit Dy. CFO banking and treasury AVP corporate finance IT 8 Note: Brand strategy and communication strategy will report functionally to CEO
9 Substantial segment and geographic diversification MULTI-SPECIALITY NETWORK 01. NMC Specialty Hospital Abu Dhabi 02. NMC Day Surgery 1 Mohammed Bin Zayed City MATERNITY & FERTILITY 17. Brightpoint Royal Women's Hospital 1 Abu Dhabi (Opened 2014) 18. Clinica Eugin 2 Spain (Acquired 2015) 26. Emirates Healthcare Dubai 27. Sheikh Khalifa Hospital Yemen DISTRIBUTION 35. NMC Warehouse DIC, Dubai 36. NMC Warehouse Ajman Ajman 03. Dr. Sunny Referral Network Sharjah (Acquired 2015) 19. Fakih IVF UAE (Acquired 2015) 28. NMC Sales and Marketing Office Abu Dhabi 04. NMC Royal Hospital 1 Khalifa City (Opened 2015) 05. NMC General Hospital 1 Dubai Investments Park (Opened 2014) 06. B.R. Medical Suites DHCC 07. NMC General Hospital Deira, Dubai 08. NMC Specialty Hospital Dubai 09. NMC Medical Centre Sharjah 10. NMC Specialty Hospital AI Ain 11. NMC Medical Centre 1 Al Ain (Opened 2014) 12. American Surgecenter Abu Dhabi 13. Al Zahra Hospital Sharjah (Acquired 2016) 14. Atlas Healthcare Muscat, Oman (Acquired 2017) LONG-TERM & HOME CARE 20. Provita Abu Dhabi (Acquired 2015) 21. Provita Al Ain (Acquired 2015) 22. Americare Abu Dhabi (Acquired 2015) 23. As Salama Saudi Arabia (Acquired 2016) 24. Chronic Care Saudi Arabia (Acquired 2016) OPERATION & MANAGEMENT 25. Sheikh Khalifa General Hospital (Operator) Umm al Quwain SAUDI ARABIA 29. NMC Sales and Marketing Office AI Ain 30. NMC Sales and Marketing Office Dubai and Northern Emirates 31. NMC Warehouse Mina. Abu Dhabi 32. NMC Warehouse AI Ain 33. NMC Warehouse DIP, Dubai 34. NMC Warehouse Al Quoz, Dubai Umm Al Quwain Sharjah Dubai UNITED ARAB EMIRATES 15. Najran Hospital Saudi Arabia (Acquired 2017) 16. Ha il Hospital Saudi Arabia (Acquired 2017) 15 YEMEN Abu Dhabi Al Ain OMAN Funded from IPO proceeds 2. Also has operations in Italy, Denmark, Brazil and Columbia
10 Operational integration Gelling the new with the old Rapid pace of acquisitions necessitates a pro-active role to balance the differences in cultures across the various entities Distribution Multi-specialty network Corporate & local culture Operations & Management Long-term & Home Care Maternity & Fertility Leadership & strategic vision Dedicated in-country specialists Well positioned to manage growth across further geographies 10 10
11 Operational integration The next phase Continuing the next phase integration of newly acquired assets whilst becoming the employer of choice in the healthcare sector Integration of culture Rolling up newly acquired assets under broader leadership to complete integration of culture Source out further efficiency opportunities Examples: ProVita / Americare, Nadia Medical Centre/ Brightpoint Royal Back office rationalisation Consolidation and rationalisation of back office functions across the portfolio Examples: NMC Sharjah, Al Zahra Hospital and Dr. Sunny Healthcare & ProVita, Americare, Emirates National Home Health Employer of choice Focus on people & culture greater alignment with employee incentives (birthday leave and tickets home) Implementation of performance management system Top Companies to Work for in the UAE ProVita, Abu Dhabi & Al Ain Americare, Abu Dhabi Brightpoint Royal Woman s Hospital, Abu Dhabi Nadia Medical Centre, Abu Dhabi Al Zahra Hospital, Sharjah New Medical Centre, Sharjah Dr Sunny Healthcare, Sharjah 11 11
12 Operational integration Optimizing existing assets Cross referrals Lab, laundry and pharmacy centralisation Back office consolidation Sales and marketing Right size organisation CONTINUED FOCUS ON OPTIMIZATION Increasing accountability Firm negotiation of rates Minimization of insurance rejection rates a key focus area 12 12
13 Operational integration Identifying the right traits for acquisition Rigorous but efficient evaluation and execution process How do we assess potential assets in KSA? Targeting pole position in the Omani Market Alignment with strategic verticals in attractive market Cultural fit with existing leadership teams and shareholders Focus on providing solid clinical care or providing clinical services that are underserved within given geography Track record of operational efficiency with upside potential Underpenetrated market with strong demand drivers Rebranded NMC portfolio Clinically stable and profitable asset base from which to expand upon Navigating the Saudi market Knowledge and expertise gained by being on the ground Oman private healthcare sector market share Investment philosophy focused on opportunity and relative value 100 beds 20% market share Comprehensive due diligence 13 13
14 Agenda 1 Welcome note from the CEO 2 NMC Healthcare Managing rapid growth 3 NMC Fertility Building a global business 4 NMC Distribution Capitalizing on synergies with Healthcare 5 Q&A 14 14
15 Getting pregnant is not that easy Variety of causes Ovulation problems 35% Others 45% Sperm production temporarily decreased Sperm obstruction 1 out of 6 every attempts results in pregnancy Blockage of Fallopian Tubes 15% 33% Endometriosis 5% Unknown causes 14% Low sperm count External causes 20% 33% Low mobility Malformed sperm with options decreasing over time 86% 78% 63% 52% 36% 0% 5% AGE 15 15
16 NMC Fertility: A globally leading, premium provider of fertility treatment NMC Fertility is the second largest player in fertility treatments globally and has a network of clinics to access patients across 3 continents 7 clinics in Europe 4 clinics in GCC 5 clinics in LatAm Full range of fertility treatments Specialized in Sharia-compliant treatment Covering a wide range of patients and offering donor cycles NMC Fertility platform has a differentiated positioning adapted to each of its markets Competitive pricing combined with medical excellence and scientific rigor with Eugin in Europe Mid-to-high end positioning in LatAm combining local doctors reputation and Eugin/Huntington brands High-end positioning for a premium clientele with Fakih in the GCC 16 16
17 A global fertility platform with leading presence in core markets Fakih Dubai Fakih No. of clinics: 1 Fakih Abu Dhabi Fakih No. of clinics¹: 2 Eugin Spain Eugin No. of clinics: 2 CIRH Eugin No. of clinics: 1 Eugin Italy Eugin No. of clinics: 3 CFC Denmark Eugin No. of clinics: 1 Eugin Colombia Eugin No. of clinics: 1 Huntington Eugin No. of clinics: 4 Current Eugin s presence Current Fakih s presence Key markets Ranking #2 #1 #1 #1 #1 Market share (by # of cycles) NMC Fertility 8% 6% 11% 36% 7% Combined top 3 players 42% 11% 28% 56% 18% Source: NMC Health estimates 17 17
18 Significant opportunity for a global leader to consolidate the fast growing fertility treatment market Top 5 players account for only c.5% global market share in a fast growing market projected at c.us$21bn by 2020 Combined top 5 players market share by number of cycles (2016): Global fertility services market (US$bn) 1 : EMEA Americas APAC 20.8 CAGR 2.6m IVF cycles globally 5% % +8.1% % 2015A 2020E Source: Technavio Global Fertility Service Market Market sizes cover the global fertility services market (including infertility drugs and services in Assisted Reproductive Technology) 18 18
19 Multi-dimensional platform well positioned for further expansion Development of pan-continental presence across the Middle East, Europe and the Americas provides scale and flexibility to drive quality, access to treatments and innovation Patient referrals and transfers within the Group Comprehensive range of fertility treatments Expertise in opening and integrating new clinics Global R&D collaborations and network Deep knowledge of all regulatory frameworks Our patients can choose to receive treatment at any facility in any country Egg, sperm and embryo movement between the clinics Transforming Europe s largest egg donation program into a global program with diversity of phenotypes Offering shariacompliant services in relevant markets Successful integration of acquisitions Track record of organic openings R&D collaborations with over 15 institutions Medical committees of renowned IVF practitioners and scientific leaders Ability to optimize use of legislations and provide innovative solutions to patients Cross-border embryo transfer 19 19
20 Agenda 1 Welcome note from the CEO 2 NMC Healthcare Managing rapid growth 3 NMC Fertility Building a global business 4 NMC Distribution Capitalizing on synergies with Healthcare 5 Q&A 20 20
21 Verticals of operations Pharma One of UAEs largest teams of medical & sales reps Visiting over 30,000 licensed doctors in UAE monthly Selling to all 1,500 pharmacies, 150 hospitals and >1,000 medical centers and clinics Medical Equipment, Consumables and Devices Solutions to the healthcare industry including Primary, Surgical, Specialty &Critical Care, Laboratory and Radio diagnostics, Medical Furniture and Rehabilitation Selling to all 1,500 pharmacies, 150 hospitals and >1,000 medical centers and clinics Veterinary Providing feed, care, grooming and medical solutions to stables, dairies, poultries, vet clinics and hospitals Consumer Education One of UAEs largest FMCG products distributor across personal care, food, beverages, household care and home improvement >7,000 points of sale across supermarkets, groceries, gas stations, hotels, cafes, wholesalers Solutions for schools including furniture, sports equipment, study aids, lab & ICT equipment 21 21
22 NMC Trading overview Sales One of the largest sales forces with a single company in the UAE Sales team of >750 professionals Value added services to establish and grow brands in the UAE market Over 10,000 customers (1,000 clinics, medical centers & hospitals, 30,000 doctors, 1500 pharmacies, 500 schools, >7,000 supermarkets, groceries, gas stations Technical Service Wide range of premier medical equipment services Authorised Service Provider (ASP) certification from multiple partners Two Specialised Biomedical Engineering Workshops with certified safety, testing and calibration analysers Marketing Focus on below the line marketing activities Typically happen at points of sale & at consumer hubs Methods include: maximizing visibility & share of shelf at point of sale, new brand launches and offer packs, retail event calendar participation Merchandizing With >400 people, one of UAEs largest teams of merchandisers Key methods include availability and visibility of products on shelf, execution of planograms, POS communications, minimize stock returns Promotions Build brand awareness by educating customers Undertake trials via dry and wet sampling for food products, organizing special promotional events such as screening camps within companies Regulatory Strong regulatory team for each vertical taking care of all compliance issues Helps partners comply with the respective regulator - municipalities, ministries & chambers of commerce Warehousing >500,000 sq ft of warehousing across the UAE Capacity of over 40,000 pallets Multiple temperature ranges including cold chain State of the art put away and pick systems minimize turnaround times and reduces error rates Analytics Investment in analytic capabilities allowing faster insights than competitors Key areas include customer channel penetration, value and order frequency, SKU product analysis, return on marketing investments, customer service reports Delivery 48-hour order to delivery commitment for all verticals Delivers >2,000 orders a day Over 250 delivery vehicles all GPS enabled allowing realtime tracking, status of delivery targets and vehicle status 22
23 Agenda 1 Welcome note from the CEO 2 NMC Healthcare Managing rapid growth 3 NMC Fertility Building a global business 4 NMC Distribution Capitalizing on synergies with Healthcare 5 Q&A 23 23
FY 2014 Results Presentation. 24 February, 2015
FY 2014 Results Presentation 24 February, 2015 Senior management presenting Prasanth Manghat Deputy CEO Roy Cherry Head of Strategy & IR Suresh Krishnamoorthy CFO 2 Contents 1. FY 2014 highlights 2. Financial
More informationFor personal use only
Virtus Health (ASX. VRT) Sue Channon CEO and Glenn Powers CFO Navigating Future Growth, UBS Australasian Conference 7 November, 2016 DISCLAIMER 2 The material in this presentation has been prepared by
More informationADM to Acquire Neovia and Probiotics International Limited. July 2, 2018
ADM to Acquire Neovia and Probiotics International Limited July 2, 2018 Safe Harbor Statement 2 Some of our comments constitute forward-looking statements that reflect management s current views and estimates
More informationThe Dental Corporation Opportunity
The Dental Corporation Opportunity for Practice Principals. It s the perfect professional collaboration. You focus on dentistry, we look after the paperwork. In recognition of what you, the Practice Principal,
More informationAn exciting combination in a high growth, high margin Nutrition category. Name of chairman
An exciting combination in a high growth, high margin Nutrition category 2 Vevey, December 14, 2006 Disclaimer This presentation contains forward looking statements which reflect Management s current views
More informationInvestor Presentation
ASX:THC B u i l d i n g a M e d i c i n a l C a n n a b i s B u s i n e s s Investor Presentation November 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an
More informationFor personal use only
ASX RELEASE (23 rd March 2018) AGM PowerPoint Presentaion In accordance with the requirements of Listing Rule 3.1 we submit the attached material being distributed at the Company s Annual General Meeting
More informationJanuary 30, 2018 Dow Wilson President and Chief Executive Officer
Acquisition of SIRTeX January 30, 2018 Dow Wilson President and Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking
More informationInfertility Treatment Devices Market by Product (Cryosystem, Imaging System, Incubator, Micromanipulator, Ovum Aspiration Pump, Sperm Analyzer,
Infertility Treatment Devices Market by Product (Cryosystem, Imaging System, Incubator, Micromanipulator, Ovum Aspiration Pump, Sperm Analyzer, Workstation), Technology (AI, Gamete Donation, IVF, ICSI,
More informationFor personal use only. Investor Briefing. Bayswater, 1 st December 2016
Investor Briefing Bayswater, 1 st December 2016 Introduction Samantha Cheetham Chief Executive Officer To be an innovative leader in the dental industry, developing our people and partnering with dentists
More informationKAPITALMARKNADSDAG 20 SEPTEMBER Thomas Axelsson, CEO
KAPITALMARKNADSDAG 20 SEPTEMBER 2016 Thomas Axelsson, CEO 1 AGENDA 16.10-16.30 VD har ordet Thomas Axelsson, CEO 16.30-16.50 Clinical relevance of time-lapse Dr. Niels B. Ramsing, Business Unit Time-lapse,
More informationGlobal Invisible Braces Market: Trends, Opportunities and Forecasts ( )
Global Invisible Braces Market: Trends, Opportunities and Forecasts (2016-2021) By Types Clear Aligners, Ceramic, Lingual By Region Americas, Europe, Middle East, Africa, Asia-Pacific By Country- USA,
More informationShareholder Presentation Annual Meeting 2018
Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)
More informationHuman Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS
Human Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS Safe harbor statement This presentation may contain forward-looking statements with respect to DSM s
More informationDelivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental
Delivering Results POSITIONED FOR GROWTH Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental PAUL GUGGENHEIM CEO, Patterson Dental Former owner and president, Guggenheim Brothers
More informationDUBAI SEIZES HALAL INITIATIVE. Farrelly & Mitchell Executive Report
DUBAI SEIZES HALAL INITIATIVE Executive Report October, 2015 Food, Beverage & Agribusiness: Commercial & Technical Due Diligence Eng. Najeeb Alhumaid Regional Manager, Middle East & Africa E: nalhumaid@farrellymitchell.com
More informationABOUT. CIEL Healthcare Limited ( CHL ), a subsidiary of CIEL Limited, is a Mauritian registered private limited
FACTSHEET ABOUT CIEL Healthcare Limited ( CHL ), a subsidiary of CIEL Limited, is a Mauritian registered private limited company, with a prime objective to own, operate and manage assets in the healthcare
More informationSTRATEGIC PLAN
STRATEGIC PLAN 2019-2028 3 EXECUTIVE SUMMARY Health at the center Good health changes everything. With good health, children can learn, parents can provide and neighbors can work together to build, and
More informationWednesday 26 th November 2008 The ASX Company Announcements office: Chairman s AGM Address
Advanced Molecular Diagnostic Systems The Walter and Eliza Hall Biotechnology Centre, 4 Research Avenue, La Trobe R&D Park, Bundoora, Victoria 3083 T: +61 (0)3 9345 2127 F: +61 (0)3 9345 2242 Wednesday
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION JUNE 2016 OTCQB:CANN ABOUT General Cannabis Corporation (GCC) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. We
More informationInvestment in MGC Pharmaceuticals
Investment in MGC Pharmaceuticals Investor Presentation May 2015 Disclaimer This presentation has been prepared by Erin Resources Limited ( Company ). It does not purport to contain all the information
More informationSTRATEGIC PLAN
2019-2022 STRATEGIC PLAN Thank you for your interest in our work! On behalf of The Friends staff and board of directors, we are excited to share our 2019-2022 Strategic Plan with you. This document represents
More informationWelcome to Galenicum! APRIL, 2013
Welcome to Galenicum! APRIL, 2013 Our corporate image comes from the sunrise. Night represents disease, daylight means health and the sunrise stands for overcoming GALENICUM CORPORATE PRESENTATION 3 Who
More informationCountry Coverage. Company Coverage
Global Heart Valve Devices Market: Analysis By Procedure (Replacement & Repair), Replacement Procedure By Technique (Mechanical, Bioprosthetic & TAVR), Repair Procedure By Technique (Surgical, Balloon
More informationGlobal Prefilled Syringes Market: Trends, Opportunities and Forecasts ( )
Global Prefilled Syringes Market: Trends, Opportunities and Forecasts (2016-2021) By Material - Glass and Plastic By Filling Capabilities Single Chamber and Dual/Multiple Chamber By Major Applications
More informationStraumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America
Media release Straumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America Group net revenue rises 2% (l.c.) as double-digit increases across America offset
More informationCommitted to Environment, Health, & Safety
Committed to Environment, Health, & Safety Environment, Health, and Safety Management System and Policy of W. R. Grace & Co. November 8, 2018 The Grace Environment, Health, and Safety Management System,
More informationimarat consultants Company Profile
imarat consultants Company Profile Sdn Bhd Registered in Malaysia, Reg No 729349-V South East Asian Office 44 Jalan Nuri 7/7 Kota Damansara 47810 Petaling Jaya Selangor Malaysia Tel/Fax: +603 6140 1477
More informationVisionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics
Dear VPEG Limited Partner, We hope this investor update finds you well. We're pleased to share with you an important update below on the following: Visionary Private Equity Group is Pleased to Announce
More informationON SHELF AVAILABILITY ALIGNMENT PROJECT 2011 ASIA PAC SURVEY RESULTS
ON SHELF AVAILABILITY ALIGNMENT PROJECT 2011 ASIA PAC SURVEY RESULTS Introduction The ECR Asia Pacific OSA working group conducted an online survey between July and September 2011 aimed at gaining insights
More informationFor personal use only
ASX ANNOUNCEMENT 22 NOVEMBER 2017 AGM ADDRESSES FROM THE CHAIRMAN & CEO 22 November 2017 Cann Group Limited (ASX: CAN) is pleased to provide the following addresses to be delivered by its Chairman Allan
More informationDIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM
November 28, 2017 DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM Dr. Jürgen Wunram Agenda Diebold Nixdorf AG History and shareholder structure Market trends, strategy and progress of integration Diebold Nixdorf
More informationBRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020
BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook Reference Code: GDMECR0130PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...
More informationEnvironmental, Health and Safety
Environmental, Health and Safety Codes of Practice The Environmental, Health and Safety (EHS) Codes of Practice set forth Zimmer EHS requirements for our business functions and facilities worldwide. In
More informationNET LEASE INVESTMENT OFFERING RITE AID PHARMACY
RITE AID PHARMACY 11702 Lorain Avenue Cleveland, OH 44111 TABLE OF CONTENTS TABLE OF CONTENTS I. Executive Profile Executive Summary Investment Highlights Property Overview II. Location Overview Photographs
More informationCommitted to Environment, Health and Safety
Committed to Environment, Health and Safety Environment, Health and Safety Management System and Policy of GCP Applied Technologies Inc. SEPTEMBER 1, 2017 The GCP Environment, Health, and Safety Management
More informationGlobal Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast ( )
Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast (2017-2022) By Region- North America, Europe, APAC and RoW By Country
More informationSegment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage
Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years): Forecast to 2022 By Type - Pap Test, HPV Test,
More informationH. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review
H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research reports
More informationGN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference. CEO GN ReSound, Mike van der Wallen September 3, 2008
GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference CEO GN ReSound, Mike van der Wallen September 3, 2008 GN Store Nord A/S GN GN Store Store Nord Nord Listed Listed company
More informationAsia-Pacific Bariatric Surgery Devices Market Outlook to 2020
Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Reference Code: GDMECR0195DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List
More informationST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015
ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 1 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the meaning of the Private Securities Litigation
More informationBoehringer Ingelheim Biopharmaceuticals in China. Your Reliable Contract Manufacturing Solution Provider
Boehringer Ingelheim Biopharmaceuticals in China Your Reliable Contract Manufacturing Solution Provider Dr. Bin Wang, Dr. Axel Schleyer Boehringer Ingelheim Biopharmaceuticals (China) Co., Ltd. Contact:
More information1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes
1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements
More informationFor personal use only
HY18 Result Presentation 13 February 2018 Dig Howitt Brent Cubis CEO & President CFO HY18 Result highlights Strong momentum across developed markets continues Developed market unit growth up 12% Strengthening
More information37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE
37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
More informationAsia-Pacific Electrophysiology Market Outlook to 2020
Asia-Pacific Electrophysiology Market Outlook to 2020 Reference Code: GDMECR0114DB Publication Date: May 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 5 1.2 List of Figures...
More informationVITROLIFE AB (PUBL) Pareto Securities Health Care Conference
VITROLIFE AB (PUBL) Pareto Securities Health Care Conference 2018-09-06 1 2 10 15 % OF ALL COUPLES IN FERTILE AGE SUFFER FROM FERTILITY PROBLEMS LEADING COMPANY IN MEDICAL DEVICES FOR ASSISTED REPRODUCTION
More informationValue growth in Human Nutrition & Health
Value growth in Human Nutrition & Health Rick Greubel President Human Nutrition & Health US Field Trip September 4, 2014 Safe harbor statement This presentation may contain forward-looking statements with
More informationSarajevo Halal Fair (SHF) 2018
Sarajevo Halal Fair (SHF) 2018 International halal industry fair with exhibition spaces (stands), presentations, business (B2B) meetings, expert and thematic panel discussions Date: September 27 to 29,
More informationLEERINK GLOBAL HEALTHCARE CONFERENCE. Marino Garcia EVP, Chief Strategy Officer February 15, 2017
LEERINK GLOBAL HEALTHCARE CONFERENCE Marino Garcia EVP, Chief Strategy Officer February 15, 2017 SAFE HARBOR STATEMENT This presentation and any statements made for and during any presentation or meeting
More information概美科技. GuideMia Technologies, LLC Sept
概美科技 info@guidemia.com GuideMia Technologies, LLC Sept 2017 +1 714 391 2739 Offering worldwide dentists and dental labs image guided implant and digital orthodontics solutions and services that change
More informationHarm de Wildt MD TNI
Harm de Wildt MD TNI Nutreco Capital Markets Day Derbyshire, UK 17 September 1 2013 Agenda 1 2 3 Market overview Animal Nutrition Europe Animal Nutrition strategic priorities Application Solution Centres
More informationBALCHEM CORPORATION. Q Investor Relations Presentation
BALCHEM CORPORATION Q4 2017 Investor Relations Presentation Balchem Corporation Balchem develops, manufactures, and markets specialty ingredients that improve and enhance the health and well being of life
More informationDevelopment Bank of Southern Africa Amendment Bill [B ]
Development Bank of Southern Africa Amendment Bill [B 2-2014] Briefing of Standing Committee on Finance National Assembly 8 July 2014 Presenters: Mr Lefentse Radikeledi Director: Asset and Liability Management
More informationNestlé. In Society. Creating Shared Value Progress and Commitments Middle East
Nestlé In Society Creating Shared Value Progress and Commitments 2020 Middle East Nestlé s purpose is about enhancing quality of life and contributing to a healthier future. We have identified three areas
More informationONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE
CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE AT KANTAR HEALTH, ONCOLOGY
More informationCHILD ENDS HERE HOMELESSNESS. 3 Year Strategic Plan Inn from the Cold 3 Year Strategic Plan
CHILD HOMELESSNESS ENDS HERE 3 Year Strategic Plan 2018-2021 a LET S HELP CHILDREN MORE Over the last 20 years, the Inn on our shelter, sanctuary and healing has grown from a grassroots organization to
More informationIn- Vitro Fertilization (IVF) - Global Market Outlook ( )
Report Information More information from: https://www.wiseguyreports.com/reports/456551-in-vitro-fertilization-ivf-global-market-outlook In- Vitro Fertilization (IVF) - Global Market Outlook (2015-2022)
More informationObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update
ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update - All Three Development Compounds Progressing with Key Clinical Milestones Over the Next 12 Months - Geneva, Switzerland
More informationCOMPANY PROFILE. AL SHAMS Group
COMPANY PROFILE AL SHAMS Group Al Shams Pharma Scintific Bureau Shams Al-Ibdaa Drug Store Bilim Pharma Co. Al-Shams Drug Store Al-Murjan Drug Store Al-Aqsa Pharmacy & Cosmetic Al-Khadraa Pharmacy & Cosmetic
More informationInvestor Relations 1Q 2017
Investor Relations 1Q 2017 History Leading Authentic Sports Brand Inspired by the Style, Elegance and Passion of our Italian Heritage Founded by FILA brothers in Biella, Italy Established FILA Korea FILA
More informationWilliam Demant. Jefferies Healthcare Conf. Nov Søren B. Andersson, VP Investor Relations
William Demant Jefferies Healthcare Conf. Nov. 2017 Søren B. Andersson, VP Investor Relations Agenda General update Key take-aways from November Interim Statement Hearing Devices Outlook 2017 Q&A 2 General
More informationCorporate Update Simon Hubbert, CEO Bill Kullback, CFO June, 2015
(Nasdaq:EVAR) Corporate Update Simon Hubbert, CEO Bill Kullback, CFO June, 2015 Safe Harbor This presentation contains forward-looking statements as that term is defined in the Private Securities Litigation
More informationAnnual Shareholders Meeting
Annual Shareholders Meeting February 8, 2018 Dow R. Wilson, President and Chief Executive Officer Forward-Looking Statements Except for historical information, this presentation contains forward-looking
More informationInvestor Day EEMA Region Lausanne, September 29, Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free
Investor Day EEMA Region Lausanne, September 29, 2016 Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free Agenda Overview and Key Results Vision and Strategic Pillars
More informationEU5 Bariatric Surgery Procedures Outlook to 2020
EU5 Bariatric Surgery Procedures Outlook to 2020 Reference Code: GDMECR0089PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...
More informationAsia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020
Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Reference Code: GDMECR0107PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3
More informationGlobal Stevia Extracts Market Analysis By Type (Dried, Leaves, Powder, Liquid), Application, Region, Country: Opportunities and Forecast ( )
Global Stevia Extracts Market Analysis By Type (Dried, Leaves, Powder, Liquid), Application, Region, Country: Opportunities and Forecast (2017-2022) Analysis By Type - Fresh/Dried leaves, Stevia powder,
More informationInvestor Presentation
Investor Presentation February 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities
More informationMexico Ostomy Drainage Bags Market Outlook to 2020
Mexico Ostomy Drainage Bags Market Outlook to 2020 Reference Code: GDMECC0990DB Publication Date: October 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List of Figures...
More informationDISCLOSEABLE AND CONNECTED TRANSACTION AND PROPOSED APPOINTMENT OF CHIEF EXECUTIVE OFFICER
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness
More informationAlpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic
Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast
More informationHILLENBRAND INDUSTRIES INC
HILLENBRAND INDUSTRIES INC FORM 8-K (Unscheduled Material Events) Filed 2/17/2004 For Period Ending 2/13/2004 Address 700 STATE ROUTE 46 E BATESVILLE, Indiana 47006-8835 Telephone 812-934-7000 CIK 0000047518
More informationConnecticut Family Stability Pay for Success Project FACT SHEET
Connecticut Family Stability Pay for Success Project FACT SHEET Ensuring Family Stability is a priority for Governor Dannel Malloy, Department of Children and Families Commissioner Joette Katz, and the
More information2018 Global Value-based Digital Dental Competitive Strategy Innovation and Leadership Award
2018 Global Value-based Digital Dental Competitive Strategy Innovation and Leadership Award 2018 Contents Background and Company Performance Industry Challenges... 3 Strategy Innovation and Customer Impact...
More informationBlood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595
Transparency Market Research Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595 Buy Now Request Sample
More informationMEMBERSHIP BOOKLET. Meeting Your Needs Through: Research, Sales Data, Staff Support, Networking
MEMBERSHIP BOOKLET Meeting Your Needs Through: Research, Sales Data, Staff Support, Networking MEMBERSHIP CATEGORIES Supplier Broker Association Allied Governmental NABCA operates on a fiscal year (July-June),
More informationPROACTIVE INVESTOR PRESENTATION
www.thcl.com.au ASX RELEASE (16 th May 2017) PROACTIVE INVESTOR PRESENTATION The Hydroponics Company Limited (ASX: THC) is pleased to advise that Dr Andrew Beehag, Chief Executive Officer of Canndeo Limited,
More informationGavi s private sector engagement approach
Gavi s 2016-2020 private sector engagement approach SCALING INNOVATION FOR IMPACT Gavi Board technical briefing session 21 June 2016 Geneva, Switzerland Reaching further, together www.gavi.org A HISTORY
More informationReport to the GAVI Alliance Board 7-8 July 2011
Report to the GAVI Alliance Board 7-8 July 2011 Subject: Report of: Authored by: GAVI Matching Fund for Immunisation David Ferreira, MD, Innovative Finance Paolo Sison, Director, Innovative Finance Agenda
More informationEPIDEMIOLOGY. Accurate, in-depth information for understanding and assessing targeted markets
EPIDEMIOLOGY Accurate, in-depth information for understanding and assessing targeted markets WHY ACCURATE MARKET FORECASTS Start with accurate understanding Epidemiology is the study of disease patterns
More informationMyriad Genetics Corporate Presentation 06/13/2018
Myriad Genetics Corporate Presentation 06/13/2018 Copyright 2016 2018 Myriad Genetics, Inc., all rights reserved. www.myriad.com. 1 Forward Looking Statements Some of the information presented here today
More informationSilica Fume Market by Application (Building Construction, Marine Structure Construction, Oil & Gas Well Grouting, Nuclear Power Plant Construction,
Silica Fume Market by Application (Building Construction, Marine Structure Construction, Oil & Gas Well Grouting, Nuclear Power Plant Construction, Chemical Production Facilities Construction, by Geography
More informationGlobal In-Vitro-Fertilization Market: Trends and Opportunities ( )
Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019) Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019) BioPortfolio has been marketing business and market
More informationInvestor Day LA&C Region Lausanne, September 29, Jeanne Pollès President, Latin America & Canada Region
Investor Day LA&C Region Lausanne, September 29, 2016 Jeanne Pollès President, Latin America & Canada Region Agenda Regional Overview and Performance Regional Strategies Key Markets Conclusion 2 LA&C Regional
More informationUpskill your staff for success
Upskill your staff for success Empower your staff by upskilling them with an Active IQ elearning course. A skilled and motivated workforce can be the difference between a good and a great organisation.
More informationAcquisition of Novartis Influenza Vaccines Business. 27 th October 2014
1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include
More informationPartnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC
Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC The patients are waiting. Dr. Paul Janssen To Our Potential
More informationChina Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020
China Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020 Reference Code: GDMECC0079DB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2
More informationPPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM
HEMATOLOGY ONCOLOGY PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM COMMITTED TO ADVANCING DRUG DEVELOPMENT IN ONCOLOGY $ MARKETPLACE COMPLEXITIES increasingly competitive marketplace and rising cost pressures
More informationOrgan Transplantation Market Research Report- Global Forecast Till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/915 Organ Transplantation Market Research Report- Global Forecast Till 2023 Report / Search Code: MRFR/HC/0410-HCRR
More informationVITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar
VITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar 2018-08-16 1 2 10 15 % OF ALL COUPLES IN FERTILE AGE SUFFER FROM FERTILITY PROBLEMS LEADING COMPANY IN MEDICAL DEVICES FOR ASSISTED REPRODUCTION A Swedish
More informationTamsulosin Hydrochloride 0.4 mg Capsule
Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule
More informationLakshy Management Consultant Pvt. Ltd.
What is ISO 13485:2003? You can t buy trust. BUILD IT through ISO 13485. Demonstrate your ability to supply medical devices through Quality Management System for Medical Devices - ISO 13485 ISO 13485 is
More informationAstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance. Becoming Global Leaders In Diabetes
AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance Becoming Global Leaders In Diabetes 19th December 2013 Cautionary Statement Regarding Forward-Looking Statements In order,
More informationRadiation Safety. Safely Working with Radioactive Materials September 2017 Dubai, U.A.E.
Radiation Safety Safely Working with Radioactive Materials 10-14 September 2017 Dubai, U.A.E. 14-DEC-16 This course is Designed, Developed, and will be Delivered under ISO Quality Standards Radiation Safety
More informationPOST SHOW REPORT. The Leading Dental Conference & Exhibition for Middle-East, Africa and South Asia markets.
The Leading Dental Conference & Exhibition for Middle-East, Africa and South Asia markets. 22 Editions of Success to Reach Excellence. Organised by Strategic Partner POST SHOW REPORT 2018 Supported by
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION May 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities regulation.
More information